Audicin
Audicin

Audicin

DR27Ahrefs DR: 27/100. Below median. Measured by Ahrefs. Median 44.Agent39Agent Readiness: 39/100. Below median. Measured by StartupHub.ai. Median 41.Speed72Site Speed: 72/100. Above median. Measured by Google PageSpeed. Median 62.

Neurotechnology company developing real-time nervous system regulation tools using science-based audio.

2022Active17Helsinki, Finland

About

Audicin is a Finland-based neurotechnology company that develops real-time nervous system regulation tools. Their technology leverages brainwave entrainment, auditory engineering, and music neuroscience to enhance focus, stress recovery, productivity, and sleep. Audicin's solutions deliver adaptive background listening sessions that respond to physiological signals, enabling continuous nervous system regulation.

Key facts

At-a-glance profile data

Website
audicin.com
Headquarters
Helsinki, Finland
Founded
2022
Employees
17
Total funding
$2M (Funding Round)
Business model
B2B2C

Funding rounds

Funding rounds raised by Audicin
DateRoundAmountLead investors
1 Apr 2026Funding Round$2M-
6 Jun 2024Seed$565KPetteri Lahtela, Virpi Tuomivaara

Tech stack

Detected on audicin.com, last scanned 17 Sept 2026. Run your own scan

Analytics
Google Tag Manager
CMS / Builders
Webflow, Shopify
CDN
Cloudflare
Email provider
Google Workspace
Cookie consent
Cookiebot
Add first review

Frequently asked

What does Audicin do?

Key offerings include Audicin for Apps, an SDK for integrating regulation protocols into digital health and consumer platforms, and a standalone Sleep Headband for offline use in environments with mobile device restrictions. The company is focused on embedding nervous system support into everyday contexts and has early commercial traction in defense, performance, and wellness sectors.

How much funding has Audicin raised?

Audicin has raised a total of $2M in funding. The most recent round on record is Funding Round.

How many employees does Audicin have?

Audicin has approximately 17 people on record.